Fully Human Antibody Targeting Human CD19 For Cancer Therapeutic Development
Canada
3075915
Filed on 2018-09-14
3075915
Filed on 2018-09-14
COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD19 IMMUNOTHERAPY
Australia
2018331517
Filed on 2020-04-14
2018331517
Filed on 2020-04-14
Methods for Producing Enriched Populations of Tumor Reactive T Cells from Peripheral Blood
China
202010410564.8
Filed on 2020-05-14
202010410564.8
Filed on 2020-05-14
METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM PERIPHERAL BLOOD
US Patent 11,679,128
Filed on 2020-06-05
Filed on 2020-06-05
T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53
Taiwan
109121744
Filed on 2020-06-26
109121744
Filed on 2020-06-26
T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53
Patent Cooperation Treaty
PCT/US2020/039785
Filed on 2020-06-26
PCT/US2020/039785
Filed on 2020-06-26
Fully Human Antibody Binders To Human CD22 For CAR-T Therapeutics Development
Canada
3078962
Filed on 2018-10-16
3078962
Filed on 2018-10-16
Fully Human Antibody Binders To Human CD22 For CAR-T Therapeutics Development
Japan
2020-521362
Filed on 2020-04-14
2020-521362
Filed on 2020-04-14
COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD22 IMMUNOTHERAPY
Australia
2018352245
Filed on 2018-10-16
2018352245
Filed on 2018-10-16
Anti-CD70 Chimeric Antigen Receptors
Hong Kong
42020011615.0
Filed on 2020-07-17
42020011615.0
Filed on 2020-07-17